{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:56:52Z","timestamp":1790542612948,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T00:00:00Z","timestamp":1629590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T00:00:00Z","timestamp":1629590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s10787-021-00866-z","type":"journal-article","created":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T05:02:25Z","timestamp":1629608545000},"page":"1539-1553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Evaluating the mucoprotective effects of glycyrrhizic acid-loaded polymeric nanoparticles in a murine model of 5-fluorouracil-induced intestinal mucositis via suppression of inflammatory mediators and oxidative stress"],"prefix":"10.1007","volume":"29","author":[{"given":"Mahira","family":"Zeeshan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Atiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qurat Ul","family":"Ain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5422-5916","authenticated-orcid":false,"given":"Hussain","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,22]]},"reference":[{"key":"866_CR1","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s11095-015-1852-6","volume":"33","author":"H Ali","year":"2016","unstructured":"Ali H, Weigmann B, Collnot E-M, Khan SA, Windbergs M, Lehr C-M (2016) Budesonide loaded PLGA nanoparticles for targeting the inflamed intestinal mucosa\u2014pharmaceutical characterization and fluorescence imaging. Pharm Res 33:1085\u20131092","journal-title":"Pharm Res"},{"key":"866_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116888","volume":"239","author":"J Ali","year":"2019","unstructured":"Ali J, Khan AU, Shah FA, Ali H, Islam SU, Kim YS, Khan S (2019) Mucoprotective effects of Saikosaponin-A in 5-fluorouracil-induced intestinal mucositis in mice model. Life Sci 239:116888","journal-title":"Life Sci"},{"key":"866_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061058","volume":"8","author":"LF Arruda","year":"2013","unstructured":"Arruda LF, Arruda SF, Campos NA, de Valencia FF, de Siqueira EMA (2013) Dietary iron concentration may influence aging process by altering oxidative stress in tissues of adult rats. PLoS ONE 8:e61058","journal-title":"PLoS ONE"},{"key":"866_CR4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ejphar.2018.12.014","volume":"843","author":"A Atiq","year":"2019","unstructured":"Atiq A et al (2019) Diadzein ameliorates 5-fluorouracil-induced intestinal mucositis by suppressing oxidative stress and inflammatory mediators in rodents. Eur J Pharmacol 843:292\u2013306. https:\/\/doi.org\/10.1016\/j.ejphar.2018.12.014","journal-title":"Eur J Pharmacol"},{"key":"866_CR5","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/cancers11060857","volume":"11","author":"D Basile","year":"2019","unstructured":"Basile D et al (2019) Mucosal injury during anti-cancer treatment: from pathobiology to bedside. Cancers 11:857","journal-title":"Cancers"},{"key":"866_CR6","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/sj.bmt.1702447","volume":"25","author":"N Blijlevens","year":"2000","unstructured":"Blijlevens N, Donnelly J, De Pauw B (2000) Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 25:1269\u20131278","journal-title":"Bone Marrow Transplant"},{"key":"866_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s40495-014-0015-5","volume":"1","author":"AM Bode","year":"2015","unstructured":"Bode AM, Dong Z (2015) Chemopreventive effects of licorice and its components. Curr Pharmacol Rep 1:60\u201371","journal-title":"Curr Pharmacol Rep"},{"key":"866_CR8","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.crhy.2011.06.001","volume":"12","author":"P Boisseau","year":"2011","unstructured":"Boisseau P, Loubaton B (2011) Nanomedicine, nanotechnology in medicine. C R Phys 12:620\u2013636","journal-title":"C R Phys"},{"key":"866_CR9","doi-asserted-by":"publisher","first-page":"e31808","DOI":"10.1371\/journal.pone.0031808","volume":"7","author":"C-T Chang","year":"2012","unstructured":"Chang C-T et al (2012) 5-Fluorouracil induced intestinal mucositis via nuclear factor-\u03baB activation by transcriptomic analysis and in vivo bioluminescence imaging. PLoS ONE 7:e31808\u2013e31808. https:\/\/doi.org\/10.1371\/journal.pone.0031808","journal-title":"PLoS ONE"},{"key":"866_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109829","volume":"124","author":"H Chen","year":"2020","unstructured":"Chen H et al (2020) Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota. Biomed Pharmacother 124:109829. https:\/\/doi.org\/10.1016\/j.biopha.2020.109829","journal-title":"Biomed Pharmacother"},{"key":"866_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejphar.2006.06.080","volume":"547","author":"J-M Cherng","year":"2006","unstructured":"Cherng J-M, Lin H-J, Hung M-S, Lin Y-R, Chan M-H, Lin J-C (2006) Inhibition of nuclear factor \u03baB is associated with neuroprotective effects of glycyrrhizic acid on glutamate-induced excitotoxicity in primary neurons. Eur J Pharmacol 547:10\u201321","journal-title":"Eur J Pharmacol"},{"key":"866_CR12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jconrel.2012.01.028","volume":"161","author":"E-M Collnot","year":"2012","unstructured":"Collnot E-M, Ali H, Lehr C-M (2012) Nano-and microparticulate drug carriers for targeting of the inflamed intestinal mucosa. J Control Release 161:235\u2013246","journal-title":"J Control Release"},{"key":"866_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"F Danhier","year":"2012","unstructured":"Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Pr\u00e9at V (2012) PLGA-based nanoparticles: an overview of biomedical applications. J Control Release 161:505\u2013522","journal-title":"J Control Release"},{"key":"866_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.toxrep.2015.10.010","volume":"3","author":"EXS dos Filho","year":"2016","unstructured":"dos Filho EXS et al (2016) Curcuminoids from Curcuma longa L. reduced intestinal mucositis induced by 5-fluorouracil in mice: Bioadhesive, proliferative, anti-inflammatory and antioxidant effects. Toxicol Rep 3:55\u201362","journal-title":"Toxicol Rep"},{"key":"866_CR15","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1046\/j.1365-2036.2003.01784.x","volume":"18","author":"M Duncan","year":"2003","unstructured":"Duncan M, Grant G (2003) Oral and intestinal mucositis\u2014causes and possible treatments. Aliment Pharmacol Ther 18:853\u2013874","journal-title":"Aliment Pharmacol Ther"},{"key":"866_CR16","first-page":"4557","volume":"7","author":"U Erben","year":"2014","unstructured":"Erben U et al (2014) A guide to histomorphological evaluation of intestinal inflammation in mouse models. Int J Clin Exp Pathol 7:4557","journal-title":"Int J Clin Exp Pathol"},{"key":"866_CR17","doi-asserted-by":"publisher","first-page":"404","DOI":"10.22038\/IJBMS.2018.27510.6714","volume":"21","author":"V Gelen","year":"2018","unstructured":"Gelen V, \u015eeng\u00fcl E, Y\u0131ld\u0131r\u0131m S, Atila G (2018) The protective effects of naringin against 5-fluorouracil-induced hepatotoxicity and nephrotoxicity in rats. Iran J Basic Med Sci 21:404\u2013410. https:\/\/doi.org\/10.22038\/IJBMS.2018.27510.6714","journal-title":"Iran J Basic Med Sci"},{"key":"866_CR18","doi-asserted-by":"publisher","first-page":"7130","DOI":"10.1016\/S0021-9258(19)42083-8","volume":"249","author":"WH Habig","year":"1974","unstructured":"Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione S-transferases the first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130\u20137139","journal-title":"J Biol Chem"},{"key":"866_CR19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.dib.2015.12.012","volume":"6","author":"MH Hadwan","year":"2016","unstructured":"Hadwan MH, Abed HN (2016) Data supporting the spectrophotometric method for the estimation of catalase activity. Data Brief 6:194\u2013199","journal-title":"Data Brief"},{"key":"866_CR20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1042\/cs0920385","volume":"92","author":"D Keefe","year":"1997","unstructured":"Keefe D, Cummins A, Dale B, Kotasek D, Robb T, Sage R (1997) Effect of high-dose chemotherapy on intestinal permeability in humans. Clin Sci (london, England: 1979) 92:385\u2013389","journal-title":"Clin Sci (london, England: 1979)"},{"key":"866_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056020","volume":"8","author":"R Khan","year":"2013","unstructured":"Khan R et al (2013) Glycyrrhizic acid suppresses the development of precancerous lesions via regulating the hyperproliferation, inflammation, angiogenesis and apoptosis in the colon of Wistar rats. PLoS ONE 8:e56020","journal-title":"PLoS ONE"},{"key":"866_CR22","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/tox.22635","volume":"33","author":"R Khan","year":"2018","unstructured":"Khan R, Rehman MU, Khan AQ, Tahir M, Sultana S (2018) Glycyrrhizic acid suppresses 1, 2-dimethylhydrazine-induced colon tumorigenesis in Wistar rats: alleviation of inflammatory, proliferation, angiogenic, and apoptotic markers. Environ Toxicol 33:1272\u20131283","journal-title":"Environ Toxicol"},{"key":"866_CR23","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/cncr.28592","volume":"120","author":"RV Lalla","year":"2014","unstructured":"Lalla RV et al (2014) MASCC\/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 120:1453\u20131461. https:\/\/doi.org\/10.1002\/cncr.28592","journal-title":"Cancer"},{"key":"866_CR24","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1080\/01635581.2015.1004730","volume":"67","author":"PC Leoc\u00e1dio","year":"2015","unstructured":"Leoc\u00e1dio PC et al (2015) L-arginine pretreatment reduces intestinal mucositis as induced by 5-FU in mice. Nutr Cancer 67:486\u2013493","journal-title":"Nutr Cancer"},{"key":"866_CR25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fcimb.2017.00455","volume":"7","author":"H-L Li","year":"2017","unstructured":"Li H-L et al (2017) Alteration of gut microbiota and inflammatory cytokine\/chemokine profiles in 5-fluorouracil induced intestinal mucositis. Front Cell Infect Microbiol 7:455","journal-title":"Front Cell Infect Microbiol"},{"key":"866_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00280-008-0732-8","volume":"63","author":"RM Logan","year":"2009","unstructured":"Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, Keefe DM (2009) Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered? Cancer Chemother Pharmacol 63:239\u2013251","journal-title":"Cancer Chemother Pharmacol"},{"key":"866_CR27","doi-asserted-by":"publisher","unstructured":"Ming LJ, Yin ACY (2013) Therapeutic effects of glycyrrhizic acid. Nat Prod Commun. https:\/\/doi.org\/10.1177\/1934578X1300800335","DOI":"10.1177\/1934578X1300800335"},{"key":"866_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/0304-4165(79)90289-7","volume":"582","author":"MS Moron","year":"1979","unstructured":"Moron MS, Depierre JW, Mannervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochimica Et Biophysica Acta (BBA) Gen Subj 582:67\u201378","journal-title":"Biochimica Et Biophysica Acta (BBA) Gen Subj"},{"key":"866_CR29","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1593\/neo.04169","volume":"6","author":"MUR Naidu","year":"2004","unstructured":"Naidu MUR, Ramana GV, Rani PU, Mohan IK, Suman A, Roy P (2004) Chemotherapy-induced and\/or radiation therapy-induced oral mucositis\u2014complicating the treatment of cancer. Neoplasia (new York, NY) 6:423","journal-title":"Neoplasia (new York, NY)"},{"key":"866_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1006\/taap.1999.8843","volume":"162","author":"BA Ploeger","year":"2000","unstructured":"Ploeger BA, Meulenbelt J, DeJongh J (2000) Physiologically based pharmacokinetic modeling of glycyrrhizic acid, a compound subject to presystemic metabolism and enterohepatic cycling. Toxicol Appl Pharmacol 162:177\u2013188","journal-title":"Toxicol Appl Pharmacol"},{"key":"866_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00280-008-0715-9","volume":"63","author":"PM Soares","year":"2008","unstructured":"Soares PM et al (2008) Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Cancer Chemother Pharmacol 63:91\u201398","journal-title":"Cancer Chemother Pharmacol"},{"key":"866_CR32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.15430\/JCP.2013.18.4.322","volume":"18","author":"M-K Song","year":"2013","unstructured":"Song M-K, Park M-Y, Sung M-K (2013) 5-Fluorouracil-induced changes of intestinal integrity biomarkers in BALB\/c mice. J Cancer Prev 18:322","journal-title":"J Cancer Prev"},{"key":"866_CR33","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3181\/0810-RM-301","volume":"234","author":"AM Stringer","year":"2009","unstructured":"Stringer AM, Gibson RJ, Logan RM, Bowen JM, Yeoh AS, Hamilton J, Keefe DM (2009) Gastrointestinal microflora and mucins may play a critical role in the development of 5-fluorouracil-induced gastrointestinal mucositis. Exp Biol Med 234:430\u2013441","journal-title":"Exp Biol Med"},{"key":"866_CR34","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.biopha.2017.08.123","volume":"95","author":"X Su","year":"2017","unstructured":"Su X, Wu L, Hu M, Dong W, Xu M, Zhang P (2017) Glycyrrhizic acid: a promising carrier material for anticancer therapy. Biomed Pharmacother 95:670\u2013678. https:\/\/doi.org\/10.1016\/j.biopha.2017.08.123","journal-title":"Biomed Pharmacother"},{"key":"866_CR35","doi-asserted-by":"publisher","first-page":"71456","DOI":"10.18632\/oncotarget.16886","volume":"8","author":"S Tadesse","year":"2017","unstructured":"Tadesse S, Corner G, Dhima E, Houston M, Guha C, Augenlicht L, Velcich A (2017) MUC2 mucin deficiency alters inflammatory and metabolic pathways in the mouse intestinal mucosa. Oncotarget 8:71456","journal-title":"Oncotarget"},{"key":"866_CR36","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.colsurfb.2018.04.047","volume":"167","author":"I Takeuchi","year":"2018","unstructured":"Takeuchi I, Kamiki Y, Makino K (2018) Therapeutic efficacy of rebamipide-loaded PLGA nanoparticles coated with chitosan in a mouse model for oral mucositis induced by cancer chemotherapy. Colloids Surf B 167:468\u2013473","journal-title":"Colloids Surf B"},{"key":"866_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000879","volume":"6","author":"MJ van Vliet","year":"2010","unstructured":"van Vliet MJ, Harmsen HJ, de Bont ES, Tissing WJ (2010) The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog 6:e1000879","journal-title":"PLoS Pathog"},{"key":"866_CR38","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.3892\/mmr.2016.4981","volume":"13","author":"YM Wang","year":"2016","unstructured":"Wang YM, Du GQ (2016) Glycyrrhizic acid prevents enteritis through reduction of NF-\u03baB p65 and p38MAPK expression in rat. Mol Med Rep 13:3639\u20133646","journal-title":"Mol Med Rep"},{"key":"866_CR39","doi-asserted-by":"publisher","first-page":"7726","DOI":"10.1021\/jf2013265","volume":"59","author":"C-Y Wang","year":"2011","unstructured":"Wang C-Y, Kao T-C, Lo W-H, Yen G-C (2011) Glycyrrhizic acid and 18\u03b2-glycyrrhetinic acid modulate lipopolysaccharide-induced inflammatory response by suppression of NF-\u03baB through PI3K p110\u03b4 and p110\u03b3 inhibitions. J Agric Food Chem 59:7726\u20137733. https:\/\/doi.org\/10.1021\/jf2013265","journal-title":"J Agric Food Chem"},{"key":"866_CR40","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.micpath.2017.05.032","volume":"109","author":"X-r Wang","year":"2017","unstructured":"Wang X-r, Hao H-g, Chu L (2017) Glycyrrhizin inhibits LPS-induced inflammatory mediator production in endometrial epithelial cells. Microbial Pathog 109:110\u2013113. https:\/\/doi.org\/10.1016\/j.micpath.2017.05.032","journal-title":"Microbial Pathog"},{"key":"866_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158851","volume":"11","author":"AL Whittaker","year":"2016","unstructured":"Whittaker AL, Lymn KA, Wallace GL, Howarth GS (2016) Differential effectiveness of clinically-relevant analgesics in a rat model of chemotherapy-induced mucositis. PLoS ONE 11:e0158851. https:\/\/doi.org\/10.1371\/journal.pone.0158851","journal-title":"PLoS ONE"},{"key":"866_CR42","doi-asserted-by":"publisher","first-page":"923","DOI":"10.4161\/cbt.8.10.8146","volume":"8","author":"TH Wright","year":"2009","unstructured":"Wright TH et al (2009) The herbal extract Iberogast\u00ae improves jejunal integrity in rats with 5-fluorouracil (5-FU)-induced mucositis. Cancer Biol Ther 8:923\u2013929","journal-title":"Cancer Biol Ther"},{"key":"866_CR43","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41401-019-0295-8","volume":"41","author":"X-x Yan","year":"2020","unstructured":"Yan X-x et al (2020) A new recombinant MS-superoxide dismutase alleviates 5-fluorouracil-induced intestinal mucositis in mice. Acta Pharmacol Sin 41:348\u2013357","journal-title":"Acta Pharmacol Sin"},{"key":"866_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12906-017-1685-4","volume":"17","author":"T Yang","year":"2017","unstructured":"Yang T et al (2017) Enhanced efficacy with reduced toxicity of chemotherapy drug 5-fluorouracil by synergistic treatment with Abnormal Savda Munziq from Uyghur medicine. BMC Complement Altern Med 17:201. https:\/\/doi.org\/10.1186\/s12906-017-1685-4","journal-title":"BMC Complement Altern Med"},{"key":"866_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138746","volume":"10","author":"C-Y Yeung","year":"2015","unstructured":"Yeung C-Y et al (2015) Amelioration of chemotherapy-induced intestinal mucositis by orally administered probiotics in a mouse model. PLoS ONE 10:e0138746","journal-title":"PLoS ONE"},{"key":"866_CR46","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/molecules21050559","volume":"21","author":"H Yuan","year":"2016","unstructured":"Yuan H, Ma Q, Ye L, Piao G (2016) The traditional medicine and modern medicine from natural products. Molecules 21:559","journal-title":"Molecules"},{"key":"866_CR47","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijpharm.2018.12.074","volume":"558","author":"M Zeeshan","year":"2019","unstructured":"Zeeshan M, Ali H, Khan S, Khan SA, Weigmann B (2019a) Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease. Int J Pharm 558:201\u2013214","journal-title":"Int J Pharm"},{"key":"866_CR48","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.2217\/nnm-2018-0415","volume":"14","author":"M Zeeshan","year":"2019","unstructured":"Zeeshan M, Ali H, Khan S, Mukhtar M, Khan MI, Arshad M (2019b) Glycyrrhizic acid-loaded pH-sensitive poly-(lactic-co-glycolic acid) nanoparticles for the amelioration of inflammatory bowel disease. Nanomedicine 14:1945\u20131969","journal-title":"Nanomedicine"},{"key":"866_CR49","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3389\/fphar.2017.00786","volume":"8","author":"T Zhang","year":"2017","unstructured":"Zhang T et al (2017a) Volatile oil from Amomi Fructus attenuates 5-fluorouracil-induced intestinal mucositis. Front Pharmacol 8:786","journal-title":"Front Pharmacol"},{"key":"866_CR50","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.biopha.2018.07.029","volume":"106","author":"S Zhang","year":"2018","unstructured":"Zhang S, Liu Y, Xiang D, Yang J, Liu D, Ren X, Zhang C (2018) Assessment of dose-response relationship of 5-fluorouracil to murine intestinal injury. Biomed Pharmacother 106:910\u2013916","journal-title":"Biomed Pharmacother"},{"key":"866_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109223","volume":"118","author":"L Zhang","year":"2019","unstructured":"Zhang L, Jin Y, Peng J, Chen W, Lisha L, Lin J (2019) Qingjie Fuzheng Granule attenuates 5-fluorouracil-induced intestinal mucosal damage. Biomed Pharmacother 118:109223. https:\/\/doi.org\/10.1016\/j.biopha.2019.109223","journal-title":"Biomed Pharmacother"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-021-00866-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-021-00866-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-021-00866-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T18:19:48Z","timestamp":1634149188000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-021-00866-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,22]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["866"],"URL":"https:\/\/doi.org\/10.1007\/s10787-021-00866-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-262247\/v1","asserted-by":"object"}]},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,22]]},"assertion":[{"value":"20 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declared no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal studies were approved and performed according to the bioethical committee protocols of Quaid-i-Azam University, Islamabad for the care and use of laboratory animals (Approval no. BES-fbs-QAU2018-75).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}